Meanwhile, as shown in Figure 3C, high- PLEKHA4 group also achieved relatively worse DSS in LGG (HR=3.11, 95% CI=2.10-4.61, P<0.001), but not in GBM (HR=1.10, 95% CI=0.70-1.45, P=0.955). This evidence concerns the gene PLEKHA4 and glioblastoma.